Picard Medical (PMI) Net Income towards Common Stockholders (2024 - 2026)

Picard Medical has reported Net Income towards Common Stockholders for 3 years, with the latest figure at -$7.6 million in Q1 2026.

• For the quarter ending Q1 2026, Net Income towards Common Stockholders fell 20.11% year-over-year to -$7.6 million; the trailing twelve-month figure through Mar 2026 stood at -$29.1 million (down 5.82% YoY), and the FY2025 full-year result was -$27.0 million, down 13.75% from the prior year.
• Net Income towards Common Stockholders for Q1 2026 stood at -$7.6 million, down from -$4.3 million in the prior quarter.
• The five-year high for Net Income towards Common Stockholders was -$4.3 million in Q4 2025, with the low at -$10.4 million in Q3 2025.
• Historically, Net Income towards Common Stockholders has averaged -$7.1 million across 3 years, with a median of -$6.8 million in 2024.
• The largest YoY upside for Net Income towards Common Stockholders was 54.87% in 2025 against a maximum downside of 51.34% in 2025.
• Picard Medical's Net Income towards Common Stockholders stood at -$9.5 million in 2024, then surged by 54.87% to -$4.3 million in 2025, then slumped by 77.49% to -$7.6 million in 2026.
• The last three Net Income towards Common Stockholders figures came in at -$7.6 million (Q1 2026), -$4.3 million (Q4 2025), and -$10.4 million (Q3 2025), per Business Quant data.